APA (7th ed.) Citation

T, A., T, S., S, G., B, Z., D, B., E, N., . . . B, R. (2025). The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: A real-world cohort study. Cardiovascular diabetology, 24(1), 97. https://doi.org/10.1186/s12933-025-02643-6

Chicago Style (17th ed.) Citation

T, Agur, Steinmetz T, Goldman S, Zingerman B, Bielopolski D, Nesher E, Fattal I, Meisel E, and Rozen-Zvi B. "The Impact of Metformin on Kidney Disease Progression and Mortality in Diabetic Patients Using SGLT2 Inhibitors: A Real-world Cohort Study." Cardiovascular Diabetology 24, no. 1 (2025): 97. https://doi.org/10.1186/s12933-025-02643-6.

MLA (9th ed.) Citation

T, Agur, et al. "The Impact of Metformin on Kidney Disease Progression and Mortality in Diabetic Patients Using SGLT2 Inhibitors: A Real-world Cohort Study." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 97, https://doi.org/10.1186/s12933-025-02643-6.